SCSK Corporation
SCSK Corporation Fundamental Analysis
SCSK Corporation (9719.T) shows moderate financial fundamentals with a PE ratio of 27.12, profit margin of 8.46%, and ROE of 21.58%. The company generates $774.3B in annual revenue with strong year-over-year growth of 24.10%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 74.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 9719.T's fundamental strength across five key dimensions:
Efficiency Score
Weak9719.T struggles to generate sufficient returns from assets.
Valuation Score
Weak9719.T trades at a premium to fair value.
Growth Score
Excellent9719.T delivers strong and consistent growth momentum.
Financial Health Score
Moderate9719.T shows balanced financial health with some risks.
Profitability Score
Moderate9719.T maintains healthy but balanced margins.
Key Financial Metrics
Is 9719.T Expensive or Cheap?
P/E Ratio
9719.T trades at 27.12 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 9719.T's PEG of 4.07 indicates potential overvaluation.
Price to Book
The market values SCSK Corporation at 5.60 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 11.16 times EBITDA. This signals the market has high growth expectations.
How Well Does 9719.T Make Money?
Net Profit Margin
For every $100 in sales, SCSK Corporation keeps $8.46 as profit after all expenses.
Operating Margin
Core operations generate 11.05 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.58 in profit for every $100 of shareholder equity.
ROA
SCSK Corporation generates $7.70 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
SCSK Corporation produces operating cash flow of $90.68B, showing steady but balanced cash generation.
Free Cash Flow
SCSK Corporation generates strong free cash flow of $77.55B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $247.95 in free cash annually.
FCF Yield
9719.T converts 4.37% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
27.12
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.07
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.60
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.29
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.26
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.08
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.16
vs 25 benchmark
How 9719.T Stacks Against Its Sector Peers
| Metric | 9719.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 27.12 | 34.43 | Better (Cheaper) |
| ROE | 21.58% | 1135.00% | Weak |
| Net Margin | 8.46% | -134663.00% (disorted) | Weak |
| Debt/Equity | 1.26 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 1.08 | 5.77 | Neutral |
| ROA | 7.70% | -310462.00% (disorted) | Weak |
9719.T outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews SCSK Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
53.88%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
56.42%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
38.87%
Industry Style: Growth, Innovation, High Beta
High Growth